• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽2型G蛋白偶联受体(VPAC2)的野生型和短缺失变体对T细胞产生白细胞介素-4的差异信号传导。

Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).

作者信息

Huang Mei-Chuan, Miller Allison L, Wang Wengang, Kong Yvonne, Paul Sudhir, Goetzl Edward J

机构信息

Department of Medicine and Microbiology-Immunology, University of California, San Francisco, CA 94143, USA.

出版信息

J Immunol. 2006 Jun 1;176(11):6640-6. doi: 10.4049/jimmunol.176.11.6640.

DOI:10.4049/jimmunol.176.11.6640
PMID:16709822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1551935/
Abstract

Vasoactive intestinal peptide (VIP) released from some neurons and T cells affects T cell migration, cytokine generation, and other functions by binding to constitutively expressed type 1 G protein-coupled receptor (VPAC1) or activation-induced type 2 G protein-coupled receptor (VPAC2). Recently, a short-deletion (SD) splice variant of mouse VPAC2 that lacks 14 amino acids at the end of the last transmembrane domain has been identified in T cells and shown to resemble wild-type (WT) VPAC2 in affinity of VIP binding but to differ by lack of signaling of T cell adenylyl cyclase, migration, and IL-2 secretion. As Th2 cells are the principal source of immune VIP and have the greatest functional responses to VIP, the differences in signals transduced by WT and SD VPAC2 were studied in VPAC2-low D10G4.1 model Th2 cell transfectants individually expressing the respective types of VPAC2 equally. WT and SD VPAC2 Th2 cell transfectants secreted equal amounts of VIP. WT VPAC2 transfectants generated more IL-4 than did SD VPAC2 transfectants, and this increment was dependent on endogenous VIP. Exogenous VIP further increased IL-4 production by WT VPAC2 transfectants but decreased IL-4 production by SD VPAC2 transfectants. Cotransfection of the two constructs diminished VIP enhancement of IL-4 production seen with WT VPAC2 alone by preventing increases in nuclear levels of the requisite transcription factors c-Maf and Jun B. Thus the ratio of two forms of T cell VPAC2 determines the net effect of VIP on IL-4 generation by activated Th2 cells.

摘要

从某些神经元和T细胞释放的血管活性肠肽(VIP)通过与组成性表达的1型G蛋白偶联受体(VPAC1)或激活诱导的2型G蛋白偶联受体(VPAC2)结合,影响T细胞迁移、细胞因子生成及其他功能。最近,在T细胞中发现了小鼠VPAC2的一种短缺失(SD)剪接变体,该变体在最后一个跨膜结构域末端缺少14个氨基酸,并且在VIP结合亲和力方面与野生型(WT)VPAC2相似,但在T细胞腺苷酸环化酶信号传导、迁移和白细胞介素-2分泌方面存在差异。由于Th2细胞是免疫VIP的主要来源,并且对VIP具有最大的功能反应,因此在VPAC2低表达的D10G4.1模型Th2细胞转染体中研究了WT和SD VPAC2转导信号的差异,这些转染体分别等量表达各自类型的VPAC2。WT和SD VPAC2 Th2细胞转染体分泌等量的VIP。WT VPAC2转染体比SD VPAC2转染体产生更多的白细胞介素-4,并且这种增加依赖于内源性VIP。外源性VIP进一步增加了WT VPAC2转染体的白细胞介素-4产生,但降低了SD VPAC2转染体的白细胞介素-4产生。两种构建体的共转染通过阻止必需转录因子c-Maf和Jun B的核水平升高,减少了单独使用WT VPAC2时观察到的VIP对白细胞介素-4产生的增强作用。因此,两种形式的T细胞VPAC2的比例决定了VIP对活化的Th2细胞产生白细胞介素-4的净效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/208c14b91afd/nihms11571f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/e7c3b7dc5475/nihms11571f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/3a5c20f60c07/nihms11571f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/3dad360b3a87/nihms11571f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/8910b738e316/nihms11571f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/9ddcec89d830/nihms11571f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/53ff13b63c40/nihms11571f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/b8f052af7ce5/nihms11571f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/208c14b91afd/nihms11571f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/e7c3b7dc5475/nihms11571f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/3a5c20f60c07/nihms11571f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/3dad360b3a87/nihms11571f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/8910b738e316/nihms11571f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/9ddcec89d830/nihms11571f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/53ff13b63c40/nihms11571f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/b8f052af7ce5/nihms11571f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7824/1551935/208c14b91afd/nihms11571f8.jpg

相似文献

1
Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).血管活性肠肽2型G蛋白偶联受体(VPAC2)的野生型和短缺失变体对T细胞产生白细胞介素-4的差异信号传导。
J Immunol. 2006 Jun 1;176(11):6640-6. doi: 10.4049/jimmunol.176.11.6640.
2
A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function.一种功能改变的血管活性肠肽天然变异型II类G蛋白偶联受体。
J Biol Chem. 2004 Sep 24;279(39):40259-62. doi: 10.1074/jbc.C400332200. Epub 2004 Aug 9.
3
VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.血管活性肠肽(VIP)受体 1(VPAC1)G 蛋白偶联受体介导 VIP 增强实验性结肠炎的作用。
Cell Immunol. 2011;267(2):124-32. doi: 10.1016/j.cellimm.2011.01.001. Epub 2011 Jan 7.
4
Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice.血管活性肠肽(VIP)在野生型小鼠和T细胞靶向性II型VIP受体转基因小鼠不同免疫表型表达中的作用。
J Immunol. 2003 Jan 1;170(1):308-14. doi: 10.4049/jimmunol.170.1.308.
5
Functional splice variants of the type II G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide in mouse and human lymphocytes.小鼠和人类淋巴细胞中血管活性肠肽的II型G蛋白偶联受体(VPAC2)的功能性剪接变体。
Ann N Y Acad Sci. 2006 Jul;1070:422-6. doi: 10.1196/annals.1317.055.
6
c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide.2型G蛋白偶联受体(VPAC2)介导的血管活性肠肽诱导Th2分化过程中c-Maf和JunB的作用
J Immunol. 2004 Jun 15;172(12):7289-96. doi: 10.4049/jimmunol.172.12.7289.
7
VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.血管活性肠肽减轻实验性胰腺炎的严重程度是由于VPAC1受体介导的细胞因子产生抑制作用。
Pancreas. 2005 Jan;30(1):62-70.
8
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.克隆的蛙血管活性肠肽/垂体腺苷酸环化酶激活肽受体具有哺乳动物中VPAC1和VPAC2受体的药理学及组织分布特征。
Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576.
9
Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor.在组成型T细胞表达诱导型血管活性肠肽受体的转基因小鼠中的过敏素质
FASEB J. 2001 Nov;15(13):2489-96. doi: 10.1096/fj.01-0671com.
10
A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.一种具有血管活性肠肽VPAC1激动剂活性和VPAC2拮抗剂作用的淋巴细胞生成片段。
J Pharmacol Exp Ther. 2003 Aug;306(2):638-45. doi: 10.1124/jpet.103.050583. Epub 2003 May 15.

引用本文的文献

1
Regulatory Peptides in Asthma.哮喘中的调节肽。
Int J Mol Sci. 2021 Dec 20;22(24):13656. doi: 10.3390/ijms222413656.
2
Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4 type 9 helper T cells and the VIP-VPAC2 signalling pathway.补肾益肺方通过负向调控 2 型固有淋巴细胞和 CD4 型 9 辅助 T 细胞及 VIP-VPAC2 信号通路缓解实验性变应性哮喘。
Pharm Biol. 2021 Dec;59(1):1216-1232. doi: 10.1080/13880209.2021.1970198.
3
Vasoactive Intestinal Polypeptide (VIP) in the Intestinal Mucosal Nerve Fibers in Dogs with Inflammatory Bowel Disease.

本文引用的文献

1
A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function.一种功能改变的血管活性肠肽天然变异型II类G蛋白偶联受体。
J Biol Chem. 2004 Sep 24;279(39):40259-62. doi: 10.1074/jbc.C400332200. Epub 2004 Aug 9.
2
VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.血管活性肠肽/垂体腺苷酸环化酶激活肽通过树突状细胞对趋化因子产生的差异调节,优先吸引Th2效应细胞。
FASEB J. 2004 Sep;18(12):1453-5. doi: 10.1096/fj.04-1548fje. Epub 2004 Jul 1.
3
c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide.
炎症性肠病犬肠道黏膜神经纤维中的血管活性肠肽(VIP)
Animals (Basel). 2020 Sep 28;10(10):1759. doi: 10.3390/ani10101759.
4
Activation of the VPAC2 Receptor Impairs Axon Outgrowth and Decreases Dendritic Arborization in Mouse Cortical Neurons by a PKA-Dependent Mechanism.通过一种依赖蛋白激酶A的机制,VPAC2受体的激活会损害小鼠皮质神经元的轴突生长并减少树突分支。
Front Neurosci. 2020 Jun 4;14:521. doi: 10.3389/fnins.2020.00521. eCollection 2020.
5
Emerging neuropeptide targets in inflammation: NPY and VIP.炎症中的新型神经肽靶点:NPY 和 VIP。
Am J Physiol Gastrointest Liver Physiol. 2013 Jun 1;304(11):G949-57. doi: 10.1152/ajpgi.00493.2012. Epub 2013 Mar 28.
6
Function of alternative splicing.可变剪接的功能。
Gene. 2013 Feb 1;514(1):1-30. doi: 10.1016/j.gene.2012.07.083. Epub 2012 Aug 15.
7
Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages. toll 样受体刺激对巨噬细胞中血管活性肠肽 2 型受体的调节作用具有差异性。
J Cell Mol Med. 2009 Sep;13(9B):3209-17. doi: 10.1111/j.1582-4934.2009.00662.x.
8
Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.G蛋白偶联受体的可变剪接:生理学与病理生理学
Cell Mol Life Sci. 2009 Oct;66(20):3337-52. doi: 10.1007/s00018-009-0093-4. Epub 2009 Jul 23.
9
Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype.缺氧标志物碳酸酐酶IX的可变剪接变体独立于缺氧和肿瘤表型表达。
Br J Cancer. 2008 Jan 15;98(1):129-36. doi: 10.1038/sj.bjc.6604111. Epub 2007 Nov 20.
10
Functional splice variants of the type II G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide in mouse and human lymphocytes.小鼠和人类淋巴细胞中血管活性肠肽的II型G蛋白偶联受体(VPAC2)的功能性剪接变体。
Ann N Y Acad Sci. 2006 Jul;1070:422-6. doi: 10.1196/annals.1317.055.
2型G蛋白偶联受体(VPAC2)介导的血管活性肠肽诱导Th2分化过程中c-Maf和JunB的作用
J Immunol. 2004 Jun 15;172(12):7289-96. doi: 10.4049/jimmunol.172.12.7289.
4
The significance of vasoactive intestinal peptide in immunomodulation.血管活性肠肽在免疫调节中的意义。
Pharmacol Rev. 2004 Jun;56(2):249-90. doi: 10.1124/pr.56.2.7.
5
Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice.血管活性肠肽(VIP)在野生型小鼠和T细胞靶向性II型VIP受体转基因小鼠不同免疫表型表达中的作用。
J Immunol. 2003 Jan 1;170(1):308-14. doi: 10.4049/jimmunol.170.1.308.
6
Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide.血管活性肠肽的免疫效应和免疫调节活性。
Regul Pept. 2002 Nov 15;109(1-3):199-208. doi: 10.1016/s0167-0115(02)00182-9.
7
Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.缺乏血管活性肠肽诱导型VPAC(2)受体的小鼠迟发型超敏反应增强,速发型超敏反应减弱。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13854-9. doi: 10.1073/pnas.241503798. Epub 2001 Nov 6.
8
Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor.在组成型T细胞表达诱导型血管活性肠肽受体的转基因小鼠中的过敏素质
FASEB J. 2001 Nov;15(13):2489-96. doi: 10.1096/fj.01-0671com.
9
Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?前沿:血管活性肠肽是2型细胞因子吗?
J Immunol. 2001 Mar 1;166(5):2907-12. doi: 10.4049/jimmunol.166.5.2907.
10
Vasoactive intestinal peptide mediation of development and functions of T lymphocytes.血管活性肠肽对T淋巴细胞发育及功能的调节作用
Ann N Y Acad Sci. 2000;921:79-91. doi: 10.1111/j.1749-6632.2000.tb06953.x.